MAXCYTE, INC. (MXCT) Stock Forecast

MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

11d ago, source: None

MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation ...

MaxCyte Inc (MXCT) Q2 2025 Earnings Report Preview: What To Expect

13d ago, source: Yahoo Finance

MaxCyte Inc (NASDAQ:MXCT) is set to release its Q2 2025 earnings on August 6, 2025. The consensus estimate for Q2 2025 ...

MaxCyte, Inc. (MXCT) Reports Q2 Loss, Misses Revenue Estimates

11d ago, source: None

MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.09 per share a year ago. These figures are ...

MaxCyte (MXCT) Signed a Strategic Platform License with Adicet Bio

on MSN ago, source: Insider Monkey on MSN.com

MaxCyte, Inc. (NASDAQ:MXCT) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 4, MaxCyte, Inc. (NASDAQ:MXCT) ...

MaxCyte, Inc. Reports Preliminary Financial Results for Fourth ... - Nasdaq

7mon ago, source: Nasdaq

MaxCyte expects full-year core revenue for 2024 to be between $32.2 million and $32.4 million, representing an 8-9% growth from 2023. When will MaxCyte's full financial results for 2024 be released?

MaxCyte, Inc. to Release Second Quarter 2025 Financial Results on ...

1mon ago, source: Nasdaq

MaxCyte, Inc., a company specializing in cell engineering to facilitate the development of cell therapeutics, announced that it will release its financial results for the second quarter of 2025 on ...

MaxCyte, Inc. (MXCT) Q4 2023 Earnings Call Transcript

1y ago, source: Seeking Alpha

MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Conference Call March 12, 2024 4:30 PM ETCompany ParticipantsSean Menarguez - Head of Investor RelationsMaher ...

MaxCyte, Inc. (MXCT) Q2 2023 Earnings Call Transcript

2y ago, source: Seeking Alpha

MaxCyte, Inc. (NASDAQ:MXCT) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ETCompany ParticipantsSean Menarguez - Head-IRDoug Doerfler - President ...

MaxCyte, Inc. to Present Positive Preclinical Data for Sickle Cell ...

8y ago, source: Business Insider

GAITHERSBURG, Md., April 25, 2017 /PRNewswire/ -- MaxCyte, a US-based global company dedicated to driving the acceleration of discovery, development, manufacturing and commercialization of next ...

Company	Ticker	90 Days Forecast	Market Cap. (USD M)	P/E	P/B
Absci Corp	ABSI	Predict	350.79	-4.73	1.76
bioAffinity Technologies, Inc.	BIAF	Predict	6.63	-1.10	3.65
bioAffinity Technologies, Inc.	BIAFW	Predict	9.35	None	3.00
Cannabis Bioscience International Holdings, Inc.	CBIH	Predict	5.47	None	None
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	CRL	Predict	7956.22	19.33	2.37
FOXO TECHNOLOGIES INC.	FOXO	Predict	0.00	None	0.00
ICON PLC	ICLR	Predict	14108.68	14.37	1.48
INCYTE CORP	INCY	Predict	17255.88	19.82	4.14
IQVIA HOLDINGS INC.	IQV	Predict	33544.46	27.12	5.81
iSpecimen Inc.	ISPC	Predict	2.68	-2.22	1.61
LUNA INNOVATIONS INC	LUNA	Predict	61.44	45.25	0.65
Medpace Holdings, Inc.	MEDP	Predict	13811.05	33.02	80.13
MAXCYTE, INC.	MXCT	Predict	144.97	-10.56	0.76
Inotiv, Inc.	NOTV	Predict	64.93	-1.30	0.45
NATIONAL RESEARCH CORP	NRC	Predict	353.72	19.73	16.59
OmniAb, Inc.	OABI	Predict	246.63	-6.45	0.94
OmniAb, Inc.	OABIW	Predict	62.93	None	0.22
OneMedNet Corp	ONMD	Predict	17.50	None	-1.06
OneMedNet Corp	ONMDW	Predict	0.71	None	-0.05